5 completed, 1 active not recruiting. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow D-Worm: new trials by email Literature Review of D-Worm trials Research Report on D-Worm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants Formulation B, Formulation C, Formulation D - Pneumococcal Disease, Invasive | Phase 2 | Active not recruiting | Inventprise Inc. | 421 | 2025-01-27 | 2025-09-02 |
| Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults Formulation A, Formulation B, Formulation C - Gastric Retention, Healthy | Early Phase 1 | Completed | Lyndra Inc. | 40 | 2018-06-25 | 2019-02-26 |
| Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants Formulation A, Formulation B, Formulation C - Healthy | Phase 1 | Completed | Janssen Sciences Ireland UC | 12 | 2015-03-04 | 2018-05-15 |
| Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults 10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 102 | 2011-11-01 | 2017-05-31 |
| Bioequivalence and Food Effect Study in Healthy Volunteers Formulation A, Formulation B, Formulation C - Sleep Initiation and Maintenance Disorders | Phase 1 | Completed | GlaxoSmithKline | 16 | 2007-07-02 | 2017-08-07 |
| Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients Formulation A, Formulation B, Formulation C - Multiple Sclerosis | Phase 1 | Completed | GlaxoSmithKline | 37 | 2007-04-21 | 2017-08-01 |
Ancylostomiasis (1) · Anemia, Iron-Deficiency (1) · Hookworm Infections (1) · Multiple Sclerosis (1) · Pneumococcal Infections (1) · Sleep Initiation and Maintenance Disorders (1)
GlaxoSmithKline (2) · Baylor College of Medicine (1) · Inventprise Inc. (1) · Janssen Sciences Ireland UC (1) · Lyndra Inc. (1)
Australia (1) · Brazil (1) · Czechia (1) · Germany (1) · Italy (1) · Philippines (1) · Poland (1) · United Kingdom (1)
David Diemert, MD (1) · Sepehr Shakib, MD (1)
2014 (1)